Robert Vendramelli

发表

A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens

D. Weiner, S. Wootton, D. Kobasa, 2021, iScience.

An S1 subunit vaccine and combination adjuvant (COVAC-1) elicits robust protection against SARS-CoV-2 challenge in African green monkeys

J. Strong, J. Audet, Zachary Schiffman, 2022, bioRxiv.

Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease

S. Booth, Jingxin Cao, D. Beniac, 2022, Journal of virology.

Pandemic 1918 Influenza Virus Does Not Cause Lethal Infection in Rhesus or Cynomolgus Macaques

J. Audet, A. Bello, D. Kobasa, 2022, Journal of virology.

A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection

Xiaojian Yao, D. Kobasa, S. Kung, 2022, Journal of virology.

Correction to: Impact of intensive care unit supportive care on the physiology of Ebola virus disease in a universally lethal non-human primate model

J. Strong, X. Qiu, G. Wong, 2019, Intensive Care Medicine Experimental.

Impact of intensive care unit supportive care on the physiology of Ebola virus disease in a universally lethal non-human primate model

J. Strong, X. Qiu, A. Bello, 2019, Intensive Care Medicine Experimental.

Generation and Characterization of a SARS-CoV-2-Susceptible Mouse Model Using Adeno-Associated Virus (AAV6.2FF)-Mediated Respiratory Delivery of the Human ACE2 Gene

S. Booth, C. Embury-Hyatt, S. Wootton, 2022, Viruses.

Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease

J. Audet, S. Booth, Jason P Knapp, 2021, iScience.

H7N9 Influenza Virus Containing a Polybasic HA Cleavage Site Requires Minimal Host Adaptation to Obtain a Highly Pathogenic Disease Phenotype in Mice

Y. Bi, G. Wong, Y. Berhane, 2020, Viruses.

SARS-CoV-2 infection and transmission in the North American deer mouse

M. Drebot, J. Strong, J. Audet, 2021, Nature Communications.

Establishment of a comprehensive and high throughput serological algorithm for Zika virus diagnostic testing.

M. Drebot, D. Safronetz, C. Ranadheera, 2019, Diagnostic microbiology and infectious disease.

Generation and Characterization of a Mouse-Adapted Makona Variant of Ebola Virus

J. Audet, D. Kobasa, A. Leung, 2019, Viruses.

Characterization of Ebola Virus Risk to Bedside Providers in an Intensive Care Environment

J. Strong, X. Qiu, G. Wong, 2021, Microorganisms.

Development and Characterization of Recombinant Vesicular Stomatitis Virus (rVSV)-based Bivalent Vaccine Against COVID-19 Delta Variant and Influenza Virus

Xiaojian Yao, S. Kung, Zhujun Ao, 2021, bioRxiv.

Endpoint Quaking-Induced Conversion: a Sensitive, Specific, and High-Throughput Method for Antemortem Diagnosis of Creutzfeldt-Jacob Disease

K. Cheng, Angela Sloan, J. D. Knox, 2016, Journal of Clinical Microbiology.

ThermoMixer-Aided Endpoint Quaking-Induced Conversion (EP-QuIC) Permits Faster Sporadic Creutzfeldt-Jakob Disease (sCJD) Identification than Real-Time Quaking-Induced Conversion (RT-QuIC)

K. Cheng, Angela Sloan, Robert Vendramelli, 2018, Journal of Clinical Microbiology.

Altered rPrP substrate structures and their influence on real-time quaking induced conversion reactions.

K. Cheng, Angela Sloan, J. D. Knox, 2018, Protein expression and purification.

Single immunization with recombinant ACAM2000 vaccinia viruses expressing the spike and the nucleocapsid proteins protect hamsters against SARS-CoV-2 caused clinical disease

S. Booth, Jingxin Cao, D. Beniac, 2021, bioRxiv.

Cell-Free Dot Blot: an Ultra-Low-Cost and Practical Immunoassay Platform for Detection of Anti-SARS-CoV-2 Antibodies in Human and Animal Sera

C. D. dos Santos, S. Babiuk, D. Kobasa, 2023, Microbiology spectrum.

Exposure route, sex, and age influence disease outcome in a golden Syrian hamster model of SARS-CoV-2 infection

J. Strong, J. Audet, A. Bello, 2021, bioRxiv.

The Nucleocapsid Proteins of SARS-CoV-2 and Its Close Relative Bat Coronavirus RaTG13 Are Capable of Inhibiting PKR- and RNase L-Mediated Antiviral Pathways

Y. Xiang, Jingxin Cao, D. Kobasa, 2023, Microbiology spectrum.

Host parameters and mode of infection influence outcome in SARS-CoV-2-infected hamsters

J. Strong, J. Audet, A. Bello, 2021, iScience.

North American deer mice are susceptible to SARS-CoV-2

M. Drebot, J. Strong, J. Audet, 2020, bioRxiv.

Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques

J. Strong, J. Audet, C. Embury-Hyatt, 2024, Vaccines.

Prion and Prion-like Diseases in Humans

G. Zanusso, A. Hughson, Robert Vendramelli, 2013, Prion.

Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges

S. Wootton, D. Kobasa, L. Susta, 2024, NPJ vaccines.

An S1 subunit vaccine and combination adjuvant (COVAC-1) elicits robust protection against SARS-CoV-2 challenge in African green monkeys

J. Strong, J. Audet, Zachary Schiffman, 2022, bioRxiv.

SARS-CoV-2 infection results in a unique lung proteome long after virus resolution in the hamster

J. Audet, D. Kobasa, B. Griffin, 2024, npj Viruses.